UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,713,835 | +10030.4% | 2,620,545 | +6581.3% | 6.69% | +9318.3% |
| Q1 2023 | $362,411 | -92.7% | 39,222 | -93.0% | 0.07% | -92.7% |
| Q4 2022 | $4,967,200 | -31.6% | 560,000 | -35.9% | 0.97% | -44.3% |
| Q3 2022 | $7,267,000 | +1.6% | 873,424 | 0.0% | 1.75% | +2.0% |
| Q2 2022 | $7,153,000 | -6.0% | 873,424 | 0.0% | 1.72% | -6.7% |
| Q1 2022 | $7,608,000 | -8.4% | 873,424 | 0.0% | 1.84% | -0.3% |
| Q4 2021 | $8,306,000 | -34.2% | 873,424 | +16.5% | 1.84% | -37.2% |
| Q3 2021 | $12,615,000 | – | 750,000 | – | 2.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |